September 21, 2023: Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment. So when nine Humira knockoffs, known as biosimilars, ...Read more >
May 24, 2021: According to a study released on May 18 by the U.S. House Oversight and Reform Committee, the pharmaceutical corporation AbbVie has raised prices 470% in the United States for its widely used drugs Humira and Imbruvica over the past two decades. The ...Read more >
February 16, 2021: Fed up with a lack of federal action to lower prescription drug costs, state legislators around the country are pushing bills to penalize drugmakers for unjustified price hikes and to cap payment at much-lower Canadian levels.
These bills, sponsor...Read more >
January 07, 2021: Sharon Clark is able to get her life-sustaining cancer drug, Pomalyst — priced at more than $18,000 for a 28-day supply — only because of the generosity of patient assistance foundations.
Clark, 57, a former insurance agent who lives in Bixby,...Read more >